Cargando…
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy
The proportions of patients with hepatocellular carcinoma (HCC) involving portal vein tumor thrombus (PVTT) varies greatly in different countries or regions, ranging from 13% to 45%. The treatment regimens for PVTT recommended by HCC guidelines in different countries or regions also vary greatly. In...
Autores principales: | Deng, Zhu-Jian, Li, Le, Teng, Yu-Xian, Zhang, Yu-Qi, Zhang, Yu-Xin, Liu, Hao-Tian, Huang, Jian-Li, Liu, Zhen-Xiu, Ma, Liang, Zhong, Jian-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845160/ https://www.ncbi.nlm.nih.gov/pubmed/35233384 http://dx.doi.org/10.14218/JCTH.2021.00179 |
Ejemplares similares
-
New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
por: Yin, Jun, et al.
Publicado: (2017) -
Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges
por: Jiang, Jin-Fang, et al.
Publicado: (2017) -
In-hospital Mortality after Surgical Resection in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus
por: Zhang, Xiu-Ping, et al.
Publicado: (2019) -
Impact of splenomegaly and splenectomy on prognosis in hepatocellular carcinoma with portal vein tumor thrombus treated with hepatectomy
por: Chai, Zong-Tao, et al.
Publicado: (2021) -
Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus
por: Yu, Tian-Zhu, et al.
Publicado: (2017)